Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Clin Breast Cancer. 2011 May 3;11(5):306–311. doi: 10.1016/j.clbc.2011.03.021

Table 1.

Patient characteristics at baseline (N=9)

Characteristic Number (%)
Median age (range) 52 (31–85)
ER and PR <10% by IHC 9 (100%)
HER2 positive (IHC 3+, FISH >2.1) 1 (11%)
Median ECOG performance status 1 (0–1)
Median number of prior chemotherapy regimens for MBC 1 (0–1)
No. patients with visceral metastases 8 (89%)